TEST

Excel version Printable version

Data dictionary : Netsarc

Patient (13 items)

Centre (NetSarc)
Type : Constrained	Content : TEXT	Mandatory : Yes	Multiple values : No	Unique : No
Description : Centre NetSarc
Possible values : KLEUVEN, MEDIPATH Toulouse, Saint-Louis, Mannheim, Cabinet de Reims, Centre Patho de Metz, Lausanne, Cabinet de Douai, Cabinet d’Amiens, Bruxelles, IHP Nantes, Paris Henri Mondor, Warsaw Cancer Center, Centre Patho Dijon, Heidelberg, Cabinet de la Roquette, Bonn, Cabinet Mathurin, Tübingen, LUMC, St Etienne ICLN-CHU, Haut-Lévèque Bordeaux, GHSN - LYON, Ambroise Paré APHP, CPS Strasbourg, Hôp. Civil Strasbourg, CHRU Montpellier, CHU Nancy, Rangueil Toulouse, Purpan Toulouse, CHRU Lille, CHRU Angers, Hôp. Nord Marseille, MEDIPATH (Frejus), APHP Bichat, APHP Saint-Antoine, Bordeaux Pellegrin, Lyon Edouard Herriot, Villejuif IGR, Hôp. Gabriel Montpied, CHRU De Dijon, Hôp. Pontchaillou, Hôp. Charles Nicolle, Hôp Pasteur, CHU Amiens, Labo. de Limoges, Service d'anapath de Brest, Cy-Path, Milan INT, Padova UNIPD, Cabinet de Rennes, Lyon CLB, Bergonié, Curie, Nice CAL, Dijon CGFL, Caen CFB, Marseille IPC, Nancy ICL, Lille COL, Montpellier ICM, Angers ICO, Nantes ICO , IUCT Toulouse, Strasbourg CHU, CJP, Timone, Cochin, Rennes CEM, Limoges Dupuytren, Tours Trousseau, Rouen CHB, Lyon IHOP, Nantes CHU, Reims IJG, Reims CHU, Besançon CHU, La Réunion CHU, Tenon, Pitié Salpétrière, CHRU Caen, CHRU Brest, Bicêtre, CHR ORLEANS, Nice CHU, Cabinet Bièvres, CHU POITIERS, OUEST PATHOLOGIE, DIAG (Nice), GRP 2 RIVES, HPL, Centre François Baclesse Luxembourg, CHU ESTAIN , MEDIPATH (Toulon)

Initials
Type : Free value	Content : TEXT	Mandatory : Yes	Multiple values : No	Unique : No
Description : Patient initials : 4 characters (2 of Lastname, 2 of Firstname)Attention to compound names

Birth date
Type : Free value	Content : DATE	Mandatory : Yes	Multiple values : No	Unique : No
Description : The patient's birth date

Sex
Type : Constrained	Content : TEXT	Mandatory : Yes	Multiple values : No	Unique : No
Description : The patient's gender
Possible values : Female, Male

Creation date patient
Type : Free value	Content : DATE	Mandatory : No	Multiple values : No	Unique : No
Description : The date when the patient has been created in the database

Patient information
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description : Consent information
Possible values : Uninformed, Addressed mail, No opposition, Opposition, Consent

Significant previous history
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : Yes	Unique : No
Description : No: no significant previous historyNF1: presence of neurofibromatosis type 1 or Recklinghausen diseaseNF2: presence of neurofibromatosis type 2Radiation therapy: tumour developed in a previously radiated areaLymphoedema: tumour developed on a preexisting lymphoedemaGardner: presence of a Gardner syndromLi Fraumeni: presence of a Li Fraumeni diseasePrevious cancer: the patient has previously developed another cancer different from the current tumourOther: other significant previous history with a possible link with the current tumour
Possible values : No, Previous cancer, NF1, NF2, Gardner syndrome, Li Fraumeni syndrome, Retinoblastoma syndrome, Immunodepressed - HIV, Immunodepressed - other, Ollier disease, Maffucci syndrome, Paget disease, Multiple osteochondromas, McCune-Albright syndrome, Rothmund-Thomson syndrome, Werner syndrome, Cherubism, Other genetic disease, Other, Unknown, Familial GISTs, Stratiakis-Carney dyad, Carney Triad, Other malignancy in family

Significant previous history detail
Type : Free value	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description :

Date of last contact
Type : Free value	Content : DATE	Mandatory : No	Multiple values : No	Unique : No
Description : Date of the last follow up evaluation or date of death

Vital status
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description : Vital status at last contact
Possible values : Alive, Dead

Diagnosis during pregnancy
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description : Diagnosis during pregnancy (CALG network enrollment)
Possible values : Yes, No

Quality control NetSarc
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description : Quality control NetSarc performed
Possible values : Yes, No

Date of control
Type : Free value	Content : DATE	Mandatory : No	Multiple values : No	Unique : No
Description : Date of quality control

Primary tumour (30 items)

Type of tumour
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description : point de départ du développement de la tumeur
Possible values : Soft tissue, Viscera, Bone

Site of tumour
Type : Constrained	Content : TEXT	Mandatory : Yes	Multiple values : No	Unique : No
Description : Site of tumour according to the scroll menu
Possible values : - Soft tissue - Head and neck - Superficial areas of head - Sinus and nasal fossa - Deep facial areas - Orbit - Anterior skull base - Ear - lateral skull base and nasoharynx - Oral cavity - oropharynx - Larynx - trachea - Visceral space of the neck - Neck NOS - Other - Trunk wall - Chest wall - Axilla - Abdominal wall - Trunk - paraspinal - Buttock - Groin - Internal trunk - Retroperitoneum - Peritoneum - Pelvis - Thorax internal - Large vessels - Paratesticular - Lower limb - Thigh - Knee - Leg - Ankle - Foot - Toe - Upper limb - Shoulder girdle - Upper arm - Elbow - Forearm - Wrist - Hand - Finger - Viscera - Gastro Intestinal tractus - Oesophagus - Stomach - Duodenum - Appendix - Small intestine - Colon - Rectum - Anus - Gyneacological area - Uterus - Ovary - Fallopian tube - Vagina - Vulva - Others - Breast - Lung - Heart - Pleura - Thymus - Thyroid - Kidney - Bladder - Ureter - Prostate - Testis - Epididymis - Penis - Spleen - Liver - Pancreas - Gallbladder - Salivary gland - Tonsil - Adrenal - Brain - Meninges - Lymph node - Bone - Skull and face bone - Skull NOS - Ethmoid - Superior maxilla - Mandible - Bone face - Upper airways - Larynx - Bronchus - Nasal septum - Spine - Cervical spine - Dorsal spine - Lumbar spine - Basin, sacrum, coccyx - Basin - Sacrum - Coccyx - Hip joint - Other thoracic bone - Rib - Sternum - Clavicle - Superior limb and shoulder - Bone shoulder girdle - Scapula - Shoulder joint - Humerus - Elbow joint - Ulna - Radius - Wirst joint - Hand bone NOS - Carpal (Hand) - Metacarpals (Hand) - Hand phalanges - Hand joint - Inferior limb - Femur - Patella - Knee joint - Tibia - Fibula - Ankle joint - Bone foot NOS - Tarsals (Foot) - Metatarsals (Foot) - Foot phalanges - Foot joint

Size of tumour (mm)
Type : Free value	Content : INTEGER	Mandatory : No	Multiple values : No	Unique : No
Description : Largest diameter of the tumour expressed in mm

Depth of tumour
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description : Superficial: the tumour is located above the superficial aponeurosis with no involvement of this aponeurosis Deep: the tumour is located beneath the superficial aponeurosis with no involvement of the area above this aponeurosis. Involvement of the aponeurosis is possibleSuperficial and deep: the tumour is located above and beneath the superficial aponeurosis
Possible values : Superficial, Superficial and deep, Deep, Surface, Cortical, Intra-medullary

Histotype
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description : Histotype of the primary tumour to be chosen in the scroll menu (2013 WHO classification, 0)
Possible values : - Benign lesion - Benign adipocytic tumours - Angiolipoma - Angiomyolipoma - Chondroid lipoma - Hibernoma - Lipoblastoma/lipoblastomatosis - Lipoma - Lipomatosis - Lipomatosis of nerve - Atypical spindle cell/pleomorphic lipomatous tumour - Myelolipoma - Myolipoma - Spindle cell / pleomorphic lipoma - Benign chondrogenic tumours - Chondroblastoma NOS - Chondroma - Chondromyxoid fibroma - Enchondroma - Osteochondroma - Osteochondromyxoma - Periosteal chondroma - Pulmonary chondroma - Pulmonary hamartoma - Subungueal exostosis - Synovial chondromatosis - Benign fibroblastic/myofibroblastic tumours - Adenofibroma - Angiofibroma - Angiomyofibroblastoma - Calcifying aponeurotic fibroma - Calcifying fibrous tumour - Cellular angiofibroma - Desmoplastic fibroblastoma - Elastofibroma - Fasciitis - Fibroblastic tumour with SMAD3 fusion - Fibrochondromyxoid tumour with THBS1 fusion - Fibro-osseous pseudotumour of digits - Fibroma of tendon sheath - Fibromatosis colli - Fibrous hamartoma of infancy - Gardner fibroma - Inclusion body fibromatosis - Intra-nodal palisaded myofibroblastoma - Ischaemic fasciitis - Juvenile hyaline fibromatosis - Myofibroblastoma - Myositis ossificans - Nasopharyngeal angiofibroma - Nodular fasciitis - Nuchal-type fibroma - Organ-associated pseudosarcomatous myofibroblastic proliferations - Other fibromas - Proliferative fasciitis - Proliferative myositis - Benign fibro-histiocytic tumours - Central giant cell granuloma of jaws (giant cell reparative granuloma of jaws) - Deep benign fibrous histiocytoma - Epithelioid fibrous histiocytoma - Erdheim-Chester disease - Fibrous histiocytoma - Giant cell lesion of the small bones (extragnathic giant cell reparative granuloma) - Langerhans cell histiocytosis - Non Ossifying fibroma - Rosai-Dorfman disease - Tenosynovial giant cell tumour NOS - Tenosynovial giant cell tumour, diffuse type - Tenosynovial giant cell tumour, localized type - Benign nerve sheath tumours - Atypical neurofibromatous neoplasm of uncertain biological potential ANNUBP - Benign Triton tumour - Dermal nerve sheath myxoma - Ectopic meningioma - Granular cell tumour - Hybrid nerve sheath tumours - Nasal glial heterotopia - Neurofibroma - Neurothekeoma - Perineurioma - Plexiform neurofibroma - Schwannoma - Solitary circumscribed neuroma - Benign notochordal tumour - Benign osteogenic tumours - Osteoid osteoma - Osteoma - Benign pericytic tumours - Angioleiomyoma - Glomus tumour - Myofibroma / myofibromatosis - Myopericytoma - Benign skeletal muscle tumours - Rhabdomyoma - Rhabdomyoma - adult type - Rhabdomyoma - fetal type - Rhabdomyoma - genital type - Benign smooth muscle tumours - Atypical polypoid adenomyoma - Adenomyoma - Bizarre nuclei leiomyoma - Cellular leiomyoma - Diffuse leiomyomatosis - Dissecans leiomyoma - Epithelioid leiomyoma - Intraveinous leiomyomatosis - Leiomyoma - Leiomyomatosis peritonealis disseminata - Mitotically-active leiomyoma - Myxoid leiomyoma - Benign tumours of uncertain differentiation - Acral fibromyxoma - Brown tumour - Deep (aggressive) angiomyxoma - Ectopic hamartomatous thymoma - Fibrous dysplasia - Inflammatory fibroid polyp - Intramuscular myxoma - Myxoma NOS - Osteofibrous dysplasia - Pleomorphic hyalinizing angiectatic tumour - Pleuropulmonary blastoma - Simple bone cyst - Superficial angiomyxoma - Benign vascular tumours - Angiolymphoid hyperplasia - Angiomatosis - Atypical vascular lesion - Diffuse pulmonary lymphangiomatosis - Epithelioid hemangioma - Gorham disease - Hemangioma - Intra-muscular hemangioma - Lymphangioma NOS - Lymphangiomatosis - Pyogenic granuloma - Osseous pseudo-tumours - Bizarre parosteal osteochondromatous proliferation - Callus - Florid ossificans periostitis - Post-traumatic fibro-osseous lesion - Tophaceous pseudogout - Other benign lesion - GIST - gastrointestinal stromal tumour (GIST), low, very low risk - gastrointestinal stromal tumour (GIST), intermediate risk - gastrointestinal stromal tumour (GIST), high risk - Non-mesenchymal malignant tumour - Carcinoma - Germinal tumor - Lymphoma - Melanoma - Myeloma - Other non-mesenchymal malignant tumours - Plasmocytoma - Other diagnoses - Diagnosis unspecified - Undifferentiated malignant tumour - Sarcoma - Chondrosarcoma - Central chondrosarcoma - Chondrosarcoma, grade 1 - Chondrosarcoma, grade 2 - Chondrosarcoma, grade 3 - Chondrosarcoma NOS - Clear cell chondrosarcoma - Dedifferentiated chondrosarcoma - Mesenchymal chondrosarcoma - Periosteal chondrosarcoma - Peripheral chondrosarcoma - Leiomyosarcoma - Leiomyosarcoma - differentiated - Leiomyosarcoma - epithelioid - Leiomyosarcoma - myxoid - Leiomyosarcoma - poorly-differentiated - Liposarcoma - Liposarcoma - dedifferentiated - Liposarcoma - mixed type - Liposarcoma - myxoid - Liposarcoma - NOS - Liposarcoma - pleomorphic - Liposarcoma - round cell - Liposarcoma - well differentiated - Myxoid pleomorphic liposarcoma - Malignant fibrohistiocytic tumours of bone - Malignant giant cell tumour of bone - Malignant peripheral nerve sheath tumour - Ectomesenchymoma - Malignant perineurioma - Malignant Triton tumour - MPNST - epithelioid type - MPNST - usual type - Miscellaneous sarcomas - Alveolar soft part sarcoma - Angiosarcoma - BCOR sarcoma - CIC-DUX sarcoma - CIC-rearranged sarcoma - Clear cell sarcoma - Desmoplastic round cell tumour - Epithelioid hemangioendothelioma NOS - Epithelioid hemangioendothelioma with TFE3 fusion - Epithelioid hemangioendothelioma with WWTR1 fusion - Epithelioid sarcoma - Ewing sarcoma - Extraskeletal myxoid chondrosarcoma - Fibrosarcoma NOS - High risk solitary fibrous tumour - Intimal sarcoma - Low grade fibromyxoid sarcoma - Low grade sinonasal sarcoma - Malignant glomus tumour - Malignant granular cell tumour - Malignant mesenchymoma - Malignant mixed tumor - Malignant myoepithelial tumour - Malignant ossifying fibromyxoid tumour - Malignant PECOMA - Malignant rhabdoid tumour - Malignant tenosynovial giant cell tumour - Primary pulmonary myxoid sarcoma with EWSR1-CREB1 fusion - Sclerosing epithelioid fibrosarcoma - SMARCA4-deficient undifferentiated thoracic tumour - Myxofibrosarcoma - Osteosarcoma - Conventional osteosarcoma - Dedifferentiated low-grade central osteosarcoma - Dedifferentiated parosteal osteosarcoma - Extraskeletal osteosarcoma - High-grade surface osteosarcoma - Low-grade central osteosarcoma - Osteoblastoma-like osteosarcoma - Osteosarcoma NOS - Parosteal osteosarcoma - Periosteal osteosarcoma - Small cell osteosarcoma - Secondary osteosarcoma - Telangiectasic osteosarcoma - Other sarcomas - Adamantinoma - Adenosarcoma - Chondroid chordoma - Chordoma NOS - Dedifferentiated adamantimoma - Dedifferentiated chordoma - Endometrial stromal sarcoma - Endometrial stromal sarcoma - high-grade - Endometrial stromal sarcoma - low-grade - Phyllodes sarcoma - Poorly differenciated chordoma - Undifferentiated uterine sarcoma - Rhabdomyosarcoma - Adult spindle cell rhabdomyosarcoma - Alveolar rhabdomyosarcoma - Embryonal rhabdomyosarcoma - botryoid type - Embryonal rhabdomyosarcoma - NOS - Embryonal rhabdomyosarcoma - spindle cell type - Embryonal rhabdomyosarcoma - usual type - Pleomorphic rhabdomyosarcoma - Rhabdomyosarcoma - NOS - Rhabdomyosarcoma with MYOD1 mutation - Rhabdomyosarcoma with TFCP2 fusion - Rhabdomyosarcoma with VGLL2/NCOA2 fusion - Sclerosing rhabdomyosarcoma - Spindle cell rhabdomyosarcoma - Suspicion of sarcoma - Synovial sarcoma - Synovial sarcoma - biphasic - Synovial sarcoma - monophasic - Synovial sarcoma - NOS - Synovial sarcoma - poorly differentiated - Undifferentiated sarcoma - Undifferentiated epithelioid sarcoma - Undifferentiated pleomorphic sarcoma - Undifferentiated round cell sarcoma - Undifferentiated sarcoma - NOS - Undifferentiated spindle cell sarcoma - Tumour of intermediate malignancy - Atypical lipomatous tumour - Intermediate chondrogenic tumours - Atypical cartilaginous tumour - Cartilaginous tumour of uncertain prognosis - Chondromatosis NOS - Intermediate fibroblastic/myofibroblastic tumours - Dermatofibrosarcoma protuberans - Desmoid-type fibromatosis - Desmoplastic fibroma of bone - Fibro-osseous tumour of bone NOS - Fibrosarcomatous dermatofibrosarcoma protuberans - Giant cell fibroblastoma - Infantile fibrosarcoma - Inflammatory myofibroblastic tumour - Intermediate risk solitary fibrous tumour - Lipofibromatosis - Low grade myofibroblastic sarcoma - Low risk solitary fibrous tumour - Myxoinflammatory fibroblastic sarcoma - NTRK-rearranged spindle cell neoplasm - Palmar/plantar fibromatosis - Superficial CD34-positive fibroblastic tumour - Intermediate fibrohistiocytic tumours - Giant cell tumour of bone - Giant cell tumour of soft tissues - Metastatic giant cell tumour of bone - Osseous tumour rich in giant cell NOS - Plexiform fibrohistiocytic tumour - Suspicion of giant cell tumour of bone - Intermediate osteogenic tumours - Osteoblastoma NOS - Osteogenic tumor of uncertain prognosis (osteoblastoma versus osteoblastoma-like osteosarcoma) - Intermediate peripheral nerve sheath tumour - Malignant melanotic neural tumour - Intermediate tumours of uncertain differentiation - Aneurysmal bone cyst - Angiomatoid fibrous histiocytoma - Atypical fibroxanthoma - Cutaneous pleomorphic sarcoma - Hemosiderotic fibrolipomatous tumour - Lymphangioleiomyoma/lymphangioleiomyomatosis - Malignant phosphaturic mesenchymal tumour - Melanotic neuroectodermal tumour of infancy - Mesenchymal tumor with GLI1 alteration - Mixed tumour - Myoepithelioma - Ossifying fibromyxoid tumour - PECOMA - NOS - Phosphaturic mesenchymal tumour NOS - Intermediate vascular tumours - Composite hemangioendothelioma - Epithelioid vascular tumour of bone NOS - Kaposi sarcoma - Kaposiform hemangioendothelioma - Papillary intralymphatic angioendothelioma - Pseudomyogenic hemangioendothelioma - Retiform hemangioendothelioma - Other tumours of intermediate malignancy - Atypical smooth muscle tumour - EBV-associated smooth muscle tumour (STUMP) - Endometrial stromal nodule - Endometrial stromal tumor low-grade - Inflammatory rhabdomyoblastic tumour - Metastatic leiomyoma - Smooth muscle tumour of undetermined malignant potential (STUMP) - Uterine tumour resembling ovarian sex cord tumours (UTROSCT) - Other intermediate mesenchymal tumour of bone - Mesenchymoma NOS - Osteofibrous dysplasia-like adamantinoma

Date of original diagnosis
Type : Free value	Content : DATE	Mandatory : No	Multiple values : No	Unique : No
Description : Date of the first sampling which allowed the diagnosis of the current tumour

Age at diagnosis
Type : Free value	Content : INTEGER	Mandatory : No	Multiple values : No	Unique : No
Description :

Diagnosis changed
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description : Modification de diagnostic (diagnostic redressé) suite à la relecture anapath. Exemple : en 2010 diagnostic de lipome relecture des lames en 2013 diagnostic de liposarcome le diagnostic est redressé donc Diagnosis changed = Yes. Exemple : diagnostic liposarcome bien différencié qui devient après rechute un liposarcome indifférentié. Diagnosis changed = No.
Possible values : No, Yes

Initial diagnosis
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description : Quel était le diagnostic avant que le redressement de diag ?
Possible values : - Benign lesion - Benign adipocytic tumours - Angiolipoma - Angiomyolipoma - Chondroid lipoma - Hibernoma - Lipoblastoma/lipoblastomatosis - Lipoma - Lipomatosis - Lipomatosis of nerve - Atypical spindle cell/pleomorphic lipomatous tumour - Myelolipoma - Myolipoma - Spindle cell / pleomorphic lipoma - Benign chondrogenic tumours - Chondroblastoma NOS - Chondroma - Chondromyxoid fibroma - Enchondroma - Osteochondroma - Osteochondromyxoma - Periosteal chondroma - Pulmonary chondroma - Pulmonary hamartoma - Subungueal exostosis - Synovial chondromatosis - Benign fibroblastic/myofibroblastic tumours - Adenofibroma - Angiofibroma - Angiomyofibroblastoma - Calcifying aponeurotic fibroma - Calcifying fibrous tumour - Cellular angiofibroma - Desmoplastic fibroblastoma - Elastofibroma - Fasciitis - Fibroblastic tumour with SMAD3 fusion - Fibrochondromyxoid tumour with THBS1 fusion - Fibro-osseous pseudotumour of digits - Fibroma of tendon sheath - Fibromatosis colli - Fibrous hamartoma of infancy - Gardner fibroma - Inclusion body fibromatosis - Intra-nodal palisaded myofibroblastoma - Ischaemic fasciitis - Juvenile hyaline fibromatosis - Myofibroblastoma - Myositis ossificans - Nasopharyngeal angiofibroma - Nodular fasciitis - Nuchal-type fibroma - Organ-associated pseudosarcomatous myofibroblastic proliferations - Other fibromas - Proliferative fasciitis - Proliferative myositis - Benign fibro-histiocytic tumours - Central giant cell granuloma of jaws (giant cell reparative granuloma of jaws) - Deep benign fibrous histiocytoma - Epithelioid fibrous histiocytoma - Erdheim-Chester disease - Fibrous histiocytoma - Giant cell lesion of the small bones (extragnathic giant cell reparative granuloma) - Langerhans cell histiocytosis - Non Ossifying fibroma - Rosai-Dorfman disease - Tenosynovial giant cell tumour NOS - Tenosynovial giant cell tumour, diffuse type - Tenosynovial giant cell tumour, localized type - Benign nerve sheath tumours - Atypical neurofibromatous neoplasm of uncertain biological potential ANNUBP - Benign Triton tumour - Dermal nerve sheath myxoma - Ectopic meningioma - Granular cell tumour - Hybrid nerve sheath tumours - Nasal glial heterotopia - Neurofibroma - Neurothekeoma - Perineurioma - Plexiform neurofibroma - Schwannoma - Solitary circumscribed neuroma - Benign notochordal tumour - Benign osteogenic tumours - Osteoid osteoma - Osteoma - Benign pericytic tumours - Angioleiomyoma - Glomus tumour - Myofibroma / myofibromatosis - Myopericytoma - Benign skeletal muscle tumours - Rhabdomyoma - Rhabdomyoma - adult type - Rhabdomyoma - fetal type - Rhabdomyoma - genital type - Benign smooth muscle tumours - Atypical polypoid adenomyoma - Adenomyoma - Bizarre nuclei leiomyoma - Cellular leiomyoma - Diffuse leiomyomatosis - Dissecans leiomyoma - Epithelioid leiomyoma - Intraveinous leiomyomatosis - Leiomyoma - Leiomyomatosis peritonealis disseminata - Mitotically-active leiomyoma - Myxoid leiomyoma - Benign tumours of uncertain differentiation - Acral fibromyxoma - Brown tumour - Deep (aggressive) angiomyxoma - Ectopic hamartomatous thymoma - Fibrous dysplasia - Inflammatory fibroid polyp - Intramuscular myxoma - Myxoma NOS - Osteofibrous dysplasia - Pleomorphic hyalinizing angiectatic tumour - Pleuropulmonary blastoma - Simple bone cyst - Superficial angiomyxoma - Benign vascular tumours - Angiolymphoid hyperplasia - Angiomatosis - Atypical vascular lesion - Diffuse pulmonary lymphangiomatosis - Epithelioid hemangioma - Gorham disease - Hemangioma - Intra-muscular hemangioma - Lymphangioma NOS - Lymphangiomatosis - Pyogenic granuloma - Osseous pseudo-tumours - Bizarre parosteal osteochondromatous proliferation - Callus - Florid ossificans periostitis - Post-traumatic fibro-osseous lesion - Tophaceous pseudogout - Other benign lesion - GIST - gastrointestinal stromal tumour (GIST), low, very low risk - gastrointestinal stromal tumour (GIST), intermediate risk - gastrointestinal stromal tumour (GIST), high risk - Non-mesenchymal malignant tumour - Carcinoma - Germinal tumor - Lymphoma - Melanoma - Myeloma - Other non-mesenchymal malignant tumours - Plasmocytoma - Other diagnoses - Diagnosis unspecified - Undifferentiated malignant tumour - Sarcoma - Chondrosarcoma - Central chondrosarcoma - Chondrosarcoma, grade 1 - Chondrosarcoma, grade 2 - Chondrosarcoma, grade 3 - Chondrosarcoma NOS - Clear cell chondrosarcoma - Dedifferentiated chondrosarcoma - Mesenchymal chondrosarcoma - Periosteal chondrosarcoma - Peripheral chondrosarcoma - Leiomyosarcoma - Leiomyosarcoma - differentiated - Leiomyosarcoma - epithelioid - Leiomyosarcoma - myxoid - Leiomyosarcoma - poorly-differentiated - Liposarcoma - Liposarcoma - dedifferentiated - Liposarcoma - mixed type - Liposarcoma - myxoid - Liposarcoma - NOS - Liposarcoma - pleomorphic - Liposarcoma - round cell - Liposarcoma - well differentiated - Myxoid pleomorphic liposarcoma - Malignant fibrohistiocytic tumours of bone - Malignant giant cell tumour of bone - Malignant peripheral nerve sheath tumour - Ectomesenchymoma - Malignant perineurioma - Malignant Triton tumour - MPNST - epithelioid type - MPNST - usual type - Miscellaneous sarcomas - Alveolar soft part sarcoma - Angiosarcoma - BCOR sarcoma - CIC-DUX sarcoma - CIC-rearranged sarcoma - Clear cell sarcoma - Desmoplastic round cell tumour - Epithelioid hemangioendothelioma NOS - Epithelioid hemangioendothelioma with TFE3 fusion - Epithelioid hemangioendothelioma with WWTR1 fusion - Epithelioid sarcoma - Ewing sarcoma - Extraskeletal myxoid chondrosarcoma - Fibrosarcoma NOS - High risk solitary fibrous tumour - Intimal sarcoma - Low grade fibromyxoid sarcoma - Low grade sinonasal sarcoma - Malignant glomus tumour - Malignant granular cell tumour - Malignant mesenchymoma - Malignant mixed tumor - Malignant myoepithelial tumour - Malignant ossifying fibromyxoid tumour - Malignant PECOMA - Malignant rhabdoid tumour - Malignant tenosynovial giant cell tumour - Primary pulmonary myxoid sarcoma with EWSR1-CREB1 fusion - Sclerosing epithelioid fibrosarcoma - SMARCA4-deficient undifferentiated thoracic tumour - Myxofibrosarcoma - Osteosarcoma - Conventional osteosarcoma - Dedifferentiated low-grade central osteosarcoma - Dedifferentiated parosteal osteosarcoma - Extraskeletal osteosarcoma - High-grade surface osteosarcoma - Low-grade central osteosarcoma - Osteoblastoma-like osteosarcoma - Osteosarcoma NOS - Parosteal osteosarcoma - Periosteal osteosarcoma - Small cell osteosarcoma - Secondary osteosarcoma - Telangiectasic osteosarcoma - Other sarcomas - Adamantinoma - Adenosarcoma - Chondroid chordoma - Chordoma NOS - Dedifferentiated adamantimoma - Dedifferentiated chordoma - Endometrial stromal sarcoma - Endometrial stromal sarcoma - high-grade - Endometrial stromal sarcoma - low-grade - Phyllodes sarcoma - Poorly differenciated chordoma - Undifferentiated uterine sarcoma - Rhabdomyosarcoma - Adult spindle cell rhabdomyosarcoma - Alveolar rhabdomyosarcoma - Embryonal rhabdomyosarcoma - botryoid type - Embryonal rhabdomyosarcoma - NOS - Embryonal rhabdomyosarcoma - spindle cell type - Embryonal rhabdomyosarcoma - usual type - Pleomorphic rhabdomyosarcoma - Rhabdomyosarcoma - NOS - Rhabdomyosarcoma with MYOD1 mutation - Rhabdomyosarcoma with TFCP2 fusion - Rhabdomyosarcoma with VGLL2/NCOA2 fusion - Sclerosing rhabdomyosarcoma - Spindle cell rhabdomyosarcoma - Suspicion of sarcoma - Synovial sarcoma - Synovial sarcoma - biphasic - Synovial sarcoma - monophasic - Synovial sarcoma - NOS - Synovial sarcoma - poorly differentiated - Undifferentiated sarcoma - Undifferentiated epithelioid sarcoma - Undifferentiated pleomorphic sarcoma - Undifferentiated round cell sarcoma - Undifferentiated sarcoma - NOS - Undifferentiated spindle cell sarcoma - Tumour of intermediate malignancy - Atypical lipomatous tumour - Intermediate chondrogenic tumours - Atypical cartilaginous tumour - Cartilaginous tumour of uncertain prognosis - Chondromatosis NOS - Intermediate fibroblastic/myofibroblastic tumours - Dermatofibrosarcoma protuberans - Desmoid-type fibromatosis - Desmoplastic fibroma of bone - Fibro-osseous tumour of bone NOS - Fibrosarcomatous dermatofibrosarcoma protuberans - Giant cell fibroblastoma - Infantile fibrosarcoma - Inflammatory myofibroblastic tumour - Intermediate risk solitary fibrous tumour - Lipofibromatosis - Low grade myofibroblastic sarcoma - Low risk solitary fibrous tumour - Myxoinflammatory fibroblastic sarcoma - NTRK-rearranged spindle cell neoplasm - Palmar/plantar fibromatosis - Superficial CD34-positive fibroblastic tumour - Intermediate fibrohistiocytic tumours - Giant cell tumour of bone - Giant cell tumour of soft tissues - Metastatic giant cell tumour of bone - Osseous tumour rich in giant cell NOS - Plexiform fibrohistiocytic tumour - Suspicion of giant cell tumour of bone - Intermediate osteogenic tumours - Osteoblastoma NOS - Osteogenic tumor of uncertain prognosis (osteoblastoma versus osteoblastoma-like osteosarcoma) - Intermediate peripheral nerve sheath tumour - Malignant melanotic neural tumour - Intermediate tumours of uncertain differentiation - Aneurysmal bone cyst - Angiomatoid fibrous histiocytoma - Atypical fibroxanthoma - Cutaneous pleomorphic sarcoma - Hemosiderotic fibrolipomatous tumour - Lymphangioleiomyoma/lymphangioleiomyomatosis - Malignant phosphaturic mesenchymal tumour - Melanotic neuroectodermal tumour of infancy - Mesenchymal tumor with GLI1 alteration - Mixed tumour - Myoepithelioma - Ossifying fibromyxoid tumour - PECOMA - NOS - Phosphaturic mesenchymal tumour NOS - Intermediate vascular tumours - Composite hemangioendothelioma - Epithelioid vascular tumour of bone NOS - Kaposi sarcoma - Kaposiform hemangioendothelioma - Papillary intralymphatic angioendothelioma - Pseudomyogenic hemangioendothelioma - Retiform hemangioendothelioma - Other tumours of intermediate malignancy - Atypical smooth muscle tumour - EBV-associated smooth muscle tumour (STUMP) - Endometrial stromal nodule - Endometrial stromal tumor low-grade - Inflammatory rhabdomyoblastic tumour - Metastatic leiomyoma - Smooth muscle tumour of uncertain malignant potential (STUMP) - Smooth muscle tumour of undetermined malignant potential (STUMP) - Uterine tumour resembling ovarian sex cord tumours (UTROSCT) - Other intermediate mesenchymal tumour of bone - Mesenchymoma NOS - Osteofibrous dysplasia-like adamantinoma

Date of review
Type : Free value	Content : DATE	Mandatory : No	Multiple values : No	Unique : No
Description : Date à laquelle la relecture anapath a permis de redresser le diagnostic.

Grade of tumour
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description : Histologic grade of the primary tumour according to the French grading system: tumour differentiation score 1 to 3, 0) + mitotic index (score 1 to 3, 0) + tumour necrosis (score 0 to 2, 0) Grade=1 for total score of 2 or 3 Grade=2 for total score of 4 or 5 Grade=3 for total score of 6, 7 or 8
Possible values : 1, 2, 3, NA

Miettinen/AFIP
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description : Risque de malignité des GIST selon Miettinen
Possible values : Very low risk, Low risk, Intermediate risk, High risk, NA

Mutation (GIST)
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description : Y a-t-il eu une recherche de mutation de faite ? Réponse possible : Non Oui et le résultat est positif Oui et le résultat est négatif Oui et le résultat n'est pas interprétable.
Possible values : No, Yes positive, Yes negative, Yes not interpretable

Radiation area
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description : Yes : tumour developed in a previously irradiated area
Possible values : No, Yes

M
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description : Yes when there is a distant metastasis diagnosed by imaging and / or histological evaluation
Possible values : Yes, No, Skip

ImagingBeforeTTT
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : Yes	Unique : No
Description :
Possible values : No, Ultrasound, CT Scan, MRI, X-Ray (standard radiograph), Other, Not available

Type of biopsy
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description : Type de biopsie à visée de diagnostic avant la chirurgie. Open biopsy : biopsie chirurgicale ou incisionnelle Biopsy NOS : Biopsie SAI Not available : Information non disponible
Possible values : No, Microbiopsy, Open biopsy, Biopsy NOS, Microbiopsy and open biopsy, Cytology only, Not available

Neo-adj ttt before surgery
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description : Traitement néo-adjuvant avant la chirurgie
Possible values : Yes, No

RCP planned surgery quality
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description : La qualité de la chirurgie a-t-elle été prévue par une des RCP précédant la chirurgie.?
Possible values : Yes, No

Surgery of tumour
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description :
Possible values : No, Yes, Curettage

Date of surgery
Type : Free value	Content : DATE	Mandatory : No	Multiple values : No	Unique : No
Description : Date of surgery

Surgeon
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description : Chirurgien qui a opéré la tumeur primaire Les chirurgiens Sarcome sont listés dans Network. Si la RCP propose que l'opération soit faite par un chirurgien particulier qui ne fait pas parti du réseau mais dont le nom est donné lors de la RCP il doit être saisi dans Referral to a specialized surgery outside network. Si le chirurgien ne correspond pas aux situations précédentes alors saisir Outside network.

Quality of 1st surgery
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description : Qualité de la première chirurgie de la tumeur primaire. R0 : résection macroscopiquement pour le chirugien et microscopiquement complète pour l'anapath. Résection monobloc. (Tumeur non vue lors de la chirurgie) R1 : résection macroscopiquement complète Si le chirurgien a vu la tumeur la résection sera au mieux R1. R2 : Résection incomplète, énucléation.
Possible values : R0 margin, R1 margin, R2 margin, Margin not evaluable, Unknown

Re-excision
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description : Reprise chirurgicale tumeur primaire Ne sont prises en compte que les reprises chirurgicales ayant lieu avant la progression ou la rechute.
Possible values : No, Yes, Curettage

Re-excision surgeon
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description : Chirurgien qui a ré-opéré la tumeur primaire Les chirurgiens sarcome sont listés dans Network. Si la RCP propose que la reprise soit faite par un chirurgien particulier qui ne fait pas parti du réseau mais dont le nom est donné lors de la RCP il doit être saisi dans Referral to a specialized surgery outside network. Si le chirurgien ne correspond pas aux situations précédentes alors saisir Outside network.

Quality of re-excision
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description : Qualité de la reprise chirurgicale de la tumeur primaire. R0 margin no tumour was found : pas de reliquat tumoral retrouvé par l'anapath dans la pièce opératoire. R0 margin and tumour was found : présence d'un reliquat tumoral et résection microscopiquement complète. R1 margin and tumour was found : reliquat présent et résection macroscopiquement complète. R2 margin and tumour was found : reliquat présent et résection incomplète. Margin not evaluable : l'anapath dit que les marges ne sont pas évaluables.
Possible values : R0 margin no tumour was found, R0 margin and tumour was found, R1 margin and tumour was found, R2 margin and tumour was found, Margin not evaluable, Unknown

Tumour spillage (CTCB)
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description : Expert pathologist observed if the tumour was spilt
Possible values : Yes, No

Progression
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description : Prend en compte la première progression locale et la première progression métastatique. Si elles sont simultannées les 2 dates sont identiques sinon elles sont différentes.
Possible values : No, Local, Metastatic, Local and metastatic, Not specify

Date 1st local progression
Type : Free value	Content : DATE	Mandatory : No	Multiple values : No	Unique : No
Description :

Date 1st metastatic progression
Type : Free value	Content : DATE	Mandatory : No	Multiple values : No	Unique : No
Description :

RCP (12 items)

File number
Type : Free value	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description : Numéro de dossier du patient dans votre établissement

Date RCP
Type : Free value	Content : DATE	Mandatory : No	Multiple values : No	Unique : No
Description : Date de la RCP

Centre of RCP
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description : Centre de RCP
Possible values : - CIRTAL National RCP - Adult Regional RCP - RCP Besançon - RCP Bordeaux - RCP Caen - RCP Clermont-Ferrand - RCP Dijon - RCP Dom Tom La Réunion - RCP Lille - RCP Limoges - RCP Lyon - RCP Marseille IPC - RCP Marseille Timone - RCP Montpellier - RCP Nancy - RCP Nantes/Angers - RCP Nice - RCP Paris APHP multisites GIST - RCP Paris Cochin - RCP Paris Curie - RCP Paris Pitié Salpetrière - RCP Paris Saint Louis - RCP Paris Tenon - RCP Poitiers - RCP Reims Debré GIST - RCP Reims Godinot - RCP Rennes/Brest - RCP Rouen - RCP Strasbourg - RCP Toulouse - RCP Tours - RCP Villejuif - Adult Inter Regional RCP - RCP IR Lille Caen Rouen Amiens - RCP IR Bordeaux Limoges Montpellier Toulouse - RCP IR Nantes Angers Rennes - RCP IR Grand Est (Nancy, Besancon, Dijon, Reims, Strasbourg) - Pediatric Inter Regional RCP - RCP pediatric Est (Besancon,Dijon,Nancy,Reims,Strasbourg) - RCP pediatric Grand Ouest (Angers,Brest,Caen,Nantes,Poitiers,Rennes,Tours) - RCP pediatric Ile de France/La Reunion - RCP pediatric Nord (Amiens,Lille,Rouen) - RCP pediatric Rhone-Alpes/Auvergne (Clermont-Ferrand,Grenoble, Lyon, Saint-Etienne) - RCP pediatric Sud Est (Marseille,Montpellier,Nice) - RCP pediatric Sud Ouest (Bordeaux,Limoges,Toulouse) - RCP regional pediatric La Reunion

Histotype
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description : Histotype of the primary tumour to be chosen in the scroll menu (2013 WHO classification, 0)
Possible values : - Benign lesion - Benign adipocytic tumours - Angiolipoma - Angiomyolipoma - Chondroid lipoma - Hibernoma - Lipoblastoma/lipoblastomatosis - Lipoma - Lipomatosis - Lipomatosis of nerve - Atypical spindle cell/pleomorphic lipomatous tumour - Myelolipoma - Myolipoma - Spindle cell / pleomorphic lipoma - Benign chondrogenic tumours - Chondroblastoma NOS - Chondroma - Chondromyxoid fibroma - Enchondroma - Osteochondroma - Osteochondromyxoma - Periosteal chondroma - Pulmonary chondroma - Pulmonary hamartoma - Subungueal exostosis - Synovial chondromatosis - Benign fibroblastic/myofibroblastic tumours - Adenofibroma - Angiofibroma - Angiomyofibroblastoma - Calcifying aponeurotic fibroma - Calcifying fibrous tumour - Cellular angiofibroma - Desmoplastic fibroblastoma - Elastofibroma - Fasciitis - Fibroblastic tumour with SMAD3 fusion - Fibrochondromyxoid tumour with THBS1 fusion - Fibro-osseous pseudotumour of digits - Fibroma of tendon sheath - Fibromatosis colli - Fibrous hamartoma of infancy - Gardner fibroma - Inclusion body fibromatosis - Intra-nodal palisaded myofibroblastoma - Ischaemic fasciitis - Juvenile hyaline fibromatosis - Myofibroblastoma - Myositis ossificans - Nasopharyngeal angiofibroma - Nodular fasciitis - Nuchal-type fibroma - Organ-associated pseudosarcomatous myofibroblastic proliferations - Other fibromas - Proliferative fasciitis - Proliferative myositis - Benign fibro-histiocytic tumours - Central giant cell granuloma of jaws (giant cell reparative granuloma of jaws) - Deep benign fibrous histiocytoma - Epithelioid fibrous histiocytoma - Erdheim-Chester disease - Fibrous histiocytoma - Giant cell lesion of the small bones (extragnathic giant cell reparative granuloma) - Langerhans cell histiocytosis - Non Ossifying fibroma - Rosai-Dorfman disease - Tenosynovial giant cell tumour NOS - Tenosynovial giant cell tumour, diffuse type - Tenosynovial giant cell tumour, localized type - Benign nerve sheath tumours - Atypical neurofibromatous neoplasm of uncertain biological potential ANNUBP - Benign Triton tumour - Dermal nerve sheath myxoma - Ectopic meningioma - Granular cell tumour - Hybrid nerve sheath tumours - Nasal glial heterotopia - Neurofibroma - Neurothekeoma - Perineurioma - Plexiform neurofibroma - Schwannoma - Solitary circumscribed neuroma - Benign notochordal tumour - Benign osteogenic tumours - Osteoid osteoma - Osteoma - Benign pericytic tumours - Angioleiomyoma - Glomus tumour - Myofibroma / myofibromatosis - Myopericytoma - Benign skeletal muscle tumours - Rhabdomyoma - Rhabdomyoma - adult type - Rhabdomyoma - fetal type - Rhabdomyoma - genital type - Benign smooth muscle tumours - Atypical polypoid adenomyoma - Adenomyoma - Bizarre nuclei leiomyoma - Cellular leiomyoma - Diffuse leiomyomatosis - Dissecans leiomyoma - Epithelioid leiomyoma - Intraveinous leiomyomatosis - Leiomyoma - Leiomyomatosis peritonealis disseminata - Mitotically-active leiomyoma - Myxoid leiomyoma - Benign tumours of uncertain differentiation - Acral fibromyxoma - Brown tumour - Deep (aggressive) angiomyxoma - Ectopic hamartomatous thymoma - Fibrous dysplasia - Inflammatory fibroid polyp - Intramuscular myxoma - Myxoma NOS - Osteofibrous dysplasia - Pleomorphic hyalinizing angiectatic tumour - Pleuropulmonary blastoma - Simple bone cyst - Superficial angiomyxoma - Benign vascular tumours - Angiolymphoid hyperplasia - Angiomatosis - Atypical vascular lesion - Diffuse pulmonary lymphangiomatosis - Epithelioid hemangioma - Gorham disease - Hemangioma - Intra-muscular hemangioma - Lymphangioma NOS - Lymphangiomatosis - Pyogenic granuloma - Osseous pseudo-tumours - Bizarre parosteal osteochondromatous proliferation - Callus - Florid ossificans periostitis - Post-traumatic fibro-osseous lesion - Tophaceous pseudogout - Other benign lesion - GIST - gastrointestinal stromal tumour (GIST), low, very low risk - gastrointestinal stromal tumour (GIST), intermediate risk - gastrointestinal stromal tumour (GIST), high risk - Non-mesenchymal malignant tumour - Carcinoma - Germinal tumor - Lymphoma - Melanoma - Myeloma - Other non-mesenchymal malignant tumours - Plasmocytoma - Other diagnoses - Diagnosis unspecified - Undifferentiated malignant tumour - Sarcoma - Chondrosarcoma - Central chondrosarcoma - Chondrosarcoma, grade 1 - Chondrosarcoma, grade 2 - Chondrosarcoma, grade 3 - Chondrosarcoma NOS - Clear cell chondrosarcoma - Dedifferentiated chondrosarcoma - Mesenchymal chondrosarcoma - Periosteal chondrosarcoma - Peripheral chondrosarcoma - Leiomyosarcoma - Leiomyosarcoma - differentiated - Leiomyosarcoma - epithelioid - Leiomyosarcoma - myxoid - Leiomyosarcoma - poorly-differentiated - Liposarcoma - Liposarcoma - dedifferentiated - Liposarcoma - mixed type - Liposarcoma - myxoid - Liposarcoma - NOS - Liposarcoma - pleomorphic - Liposarcoma - round cell - Liposarcoma - well differentiated - Myxoid pleomorphic liposarcoma - Malignant fibrohistiocytic tumours of bone - Malignant giant cell tumour of bone - Malignant peripheral nerve sheath tumour - Ectomesenchymoma - Malignant perineurioma - Malignant Triton tumour - MPNST - epithelioid type - MPNST - usual type - Miscellaneous sarcomas - Alveolar soft part sarcoma - Angiosarcoma - BCOR sarcoma - CIC-DUX sarcoma - CIC-rearranged sarcoma - Clear cell sarcoma - Desmoplastic round cell tumour - Epithelioid hemangioendothelioma NOS - Epithelioid hemangioendothelioma with TFE3 fusion - Epithelioid hemangioendothelioma with WWTR1 fusion - Epithelioid sarcoma - Ewing sarcoma - Extraskeletal myxoid chondrosarcoma - Fibrosarcoma NOS - High risk solitary fibrous tumour - Intimal sarcoma - Low grade fibromyxoid sarcoma - Low grade sinonasal sarcoma - Malignant glomus tumour - Malignant granular cell tumour - Malignant mesenchymoma - Malignant mixed tumor - Malignant myoepithelial tumour - Malignant ossifying fibromyxoid tumour - Malignant PECOMA - Malignant rhabdoid tumour - Malignant tenosynovial giant cell tumour - Primary pulmonary myxoid sarcoma with EWSR1-CREB1 fusion - Sclerosing epithelioid fibrosarcoma - SMARCA4-deficient undifferentiated thoracic tumour - Myxofibrosarcoma - Osteosarcoma - Conventional osteosarcoma - Dedifferentiated low-grade central osteosarcoma - Dedifferentiated parosteal osteosarcoma - Extraskeletal osteosarcoma - High-grade surface osteosarcoma - Low-grade central osteosarcoma - Osteoblastoma-like osteosarcoma - Osteosarcoma NOS - Parosteal osteosarcoma - Periosteal osteosarcoma - Small cell osteosarcoma - Secondary osteosarcoma - Telangiectasic osteosarcoma - Other sarcomas - Adamantinoma - Adenosarcoma - Chondroid chordoma - Chordoma NOS - Dedifferentiated adamantimoma - Dedifferentiated chordoma - Endometrial stromal sarcoma - Endometrial stromal sarcoma - high-grade - Endometrial stromal sarcoma - low-grade - Phyllodes sarcoma - Poorly differenciated chordoma - Undifferentiated uterine sarcoma - Rhabdomyosarcoma - Adult spindle cell rhabdomyosarcoma - Alveolar rhabdomyosarcoma - Embryonal rhabdomyosarcoma - botryoid type - Embryonal rhabdomyosarcoma - NOS - Embryonal rhabdomyosarcoma - spindle cell type - Embryonal rhabdomyosarcoma - usual type - Pleomorphic rhabdomyosarcoma - Rhabdomyosarcoma - NOS - Rhabdomyosarcoma with MYOD1 mutation - Rhabdomyosarcoma with TFCP2 fusion - Rhabdomyosarcoma with VGLL2/NCOA2 fusion - Sclerosing rhabdomyosarcoma - Spindle cell rhabdomyosarcoma - Suspicion of sarcoma - Synovial sarcoma - Synovial sarcoma - biphasic - Synovial sarcoma - monophasic - Synovial sarcoma - NOS - Synovial sarcoma - poorly differentiated - Undifferentiated sarcoma - Undifferentiated epithelioid sarcoma - Undifferentiated pleomorphic sarcoma - Undifferentiated round cell sarcoma - Undifferentiated sarcoma - NOS - Undifferentiated spindle cell sarcoma - Tumour of intermediate malignancy - Atypical lipomatous tumour - Intermediate chondrogenic tumours - Atypical cartilaginous tumour - Cartilaginous tumour of uncertain prognosis - Chondromatosis NOS - Intermediate fibroblastic/myofibroblastic tumours - Dermatofibrosarcoma protuberans - Desmoid-type fibromatosis - Desmoplastic fibroma of bone - Fibro-osseous tumour of bone NOS - Fibrosarcomatous dermatofibrosarcoma protuberans - Giant cell fibroblastoma - Infantile fibrosarcoma - Inflammatory myofibroblastic tumour - Intermediate risk solitary fibrous tumour - Lipofibromatosis - Low grade myofibroblastic sarcoma - Low risk solitary fibrous tumour - Myxoinflammatory fibroblastic sarcoma - NTRK-rearranged spindle cell neoplasm - Palmar/plantar fibromatosis - Superficial CD34-positive fibroblastic tumour - Intermediate fibrohistiocytic tumours - Giant cell tumour of bone - Giant cell tumour of soft tissues - Metastatic giant cell tumour of bone - Osseous tumour rich in giant cell NOS - Plexiform fibrohistiocytic tumour - Suspicion of giant cell tumour of bone - Intermediate osteogenic tumours - Osteoblastoma NOS - Osteogenic tumor of uncertain prognosis (osteoblastoma versus osteoblastoma-like osteosarcoma) - Intermediate peripheral nerve sheath tumour - Malignant melanotic neural tumour - Intermediate tumours of uncertain differentiation - Aneurysmal bone cyst - Angiomatoid fibrous histiocytoma - Atypical fibroxanthoma - Cutaneous pleomorphic sarcoma - Hemosiderotic fibrolipomatous tumour - Lymphangioleiomyoma/lymphangioleiomyomatosis - Malignant phosphaturic mesenchymal tumour - Melanotic neuroectodermal tumour of infancy - Mesenchymal tumor with GLI1 alteration - Mixed tumour - Myoepithelioma - Ossifying fibromyxoid tumour - PECOMA - NOS - Phosphaturic mesenchymal tumour NOS - Intermediate vascular tumours - Composite hemangioendothelioma - Epithelioid vascular tumour of bone NOS - Kaposi sarcoma - Kaposiform hemangioendothelioma - Papillary intralymphatic angioendothelioma - Pseudomyogenic hemangioendothelioma - Retiform hemangioendothelioma - Other tumours of intermediate malignancy - Atypical smooth muscle tumour - EBV-associated smooth muscle tumour (STUMP) - Endometrial stromal nodule - Endometrial stromal tumor low-grade - Inflammatory rhabdomyoblastic tumour - Metastatic leiomyoma - Smooth muscle tumour of undetermined malignant potential (STUMP) - Uterine tumour resembling ovarian sex cord tumours (UTROSCT) - Other intermediate mesenchymal tumour of bone - Mesenchymoma NOS - Osteofibrous dysplasia-like adamantinoma

Clinical situation
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description : Situation de la prise en charge du patient lors de la RCP Si un patient a progressé il sera toujours en After progresssion pour toutes les RCP suivantes
Possible values : Before biopsy, Before neo-adjuvant treatment, Before surgery, Complementary treatment, After treatment, After progression

Decision 1
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description :
Possible values : - Indication for biopsy - Indication for staging - Indication for histological review - Indication for surgery - Indication for initial tumour surgery - Indication for metastasis surgery - Chemoembolisation - Radiofrequency - Cryotherapy - Indication for re-excision - Indication for ILP - No indication for surgery - Indication for radiotherapy - Indication for neoadjuvant radiotherapy - Indication for adjuvant radiotherapy - Indication for exclusive or palliative radiotherapy - No indication for radiotherapy - Indication for chemotherapy - Indication for neoadjuvant chemotherapy - Indication for adjuvant chemotherapy - Indication for metastatic chemotherapy - Targeted therapies - Continuation of chemotherapy protocol - Modification of chemotherapy dose - Modification of chemotherapy protocol - No indication for chemotherapy - Supportive or palliative care - Indication for hormone therapy - NSAI - Others - No indication for additional treatment - Request for supplementary examinations - Indication for surveillance program - Advisory opinion from another MCB - Advisory opinion from other specialists - Medical file to present (again) to a MCB

Decision 2
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description :
Possible values : - Indication for biopsy - Indication for staging - Indication for histological review - Indication for surgery - Indication for initial tumour surgery - Indication for metastasis surgery - Chemoembolization - Radiofrequency - Cryotherapy - Indication for re-excision - Indication for ILP - No indication for surgery - Indication for radiotherapy - Indication for neoadjuvant radiotherapy - Indication for adjuvant radiotherapy - Indication for exclusive or palliative radiotherapy - No indication for radiotherapy - Indication for chemotherapy - Indication for neoadjuvant chemotherapy - Indication for adjuvant chemotherapy - Indication for metastatic chemotherapy - Targeted therapies - Continuation of chemotherapy protocol - Modification of chemotherapy dose - Modification of chemotherapy protocol - No indication for chemotherapy - Supportive or palliative care - Indication for hormone therapy - NSAI - Others - No indication for additional treatment - Request for supplementary examinations - Indication for surveillance program - Advisory opinion from another MCB - Advisory opinion from other specialists - Medical file to present (again) to a MCB

Decision 3
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description :
Possible values : - Indication for biopsy - Indication for staging - Indication for histological review - Indication for surgery - Indication for initial tumour surgery - Indication for metastasis surgery - Chemoembolisation - Radiofrequency - Cryotherapy - Indication for re-excision - Indication for ILP - No indication for surgery - Indication for radiotherapy - Indication for neoadjuvant radiotherapy - Indication for adjuvant radiotherapy - Indication for exclusive or palliative radiotherapy - No indication for radiotherapy - Indication for chemotherapy - Indication for neoadjuvant chemotherapy - Indication for adjuvant chemotherapy - Indication for metastatic chemotherapy - Targeted therapies - Continuation of chemotherapy protocol - Modification of chemotherapy dose - Modification of chemotherapy protocol - No indication of chemotherapy - Supportive or palliative care - Indication for hormone therapy - NSAI - Others - No indication for additional treatment - Request for supplementary examinations - Indication for surveillance program - Advisory opinion from another MCB - Advisory opinion from other specialists - Medical file to present (again) to a MCB

Requesting center
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description : Établissement ou personne (médecin généraliste) adressant le patient en RCP
Possible values : Attending physician, Comprehensive Cancer Center, Universitary Hospital, General Hospital, PSPH, Private institution

CT enrollment Proposal
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description : Essais clinique proposé par la RCP
Possible values : Yes, No

CtEnrollmentComment
Type : Free value	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description : CT enrollment comment

Comment
Type : Free value	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description :

Trial inclusion (5 items)

File number
Type : Free value	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description : Numéro de dossier du patient dans votre établissement

Inclusion date
Type : Free value	Content : DATE	Mandatory : No	Multiple values : No	Unique : No
Description : Date de l'inclusion dans l'essai clinique (signature du consentement)

Clinical trial
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description : Essai Clinique dans lequel le patient est inclus
Possible values : RT-SU, Other, PAL ANGI 3, SYNFRIZZ, LMS-02, TRUST 62091 EORTC, PAZOGIST, T-DIS-1001, CASSANDRE-1108, APLIPO, ANGIONEXT 0710, LMS-03 (Sarcome 11), DESMOPAZ, ANGIOTAX-PLUS-0906, TOMOREP, FIBROMATOSE WS-RT, DFSP-PAZO, OS II TTP, AcSé Crizotinib, VIT 0910, REGOSARC-1214, CHONDROG, ESTIM LBH, RMS 2005, NRSTS 2005 EPSSG, OS 2006 (Sarcome 9), STRASS 62092 EORTC, Euro-Ewing 99 (Sarcome 1 - EORTC 62981), API-AI (Sarcome 3), 08 SARC 01 (RT-Sarc), SARC-GYN 1, PALSAR II 98 (Sarcome 2), TEPOSSE, ANGI-HE-1110, OUTC'S, GENEWING, SARI, ProActYon, RETROSPECTYON, ISKS , PROFILER, POLY NCR3-TNF GIST, SARCOLIGO, TKI-CPK-1003, IFOS-1, SAKK 56-07, Sarcome 07/0410 (Sarcome 7), Sarcome 04/0205 (Sarcome 4), Sarcome 08/0411 EORTC 62024 (Sarcome 8), EORTC 90061, EORTC 62061, BFR14, SURGIST Sarcome 10/0805 62063 (Sarcome 10), EORTC 62012, EUROSARC ISG-STS 10-01, CREATE EORTC 90101, GOG 0277 / EORTC 55116-62114, ImadGIST, CABONE, CHONRAD, ALDOXORUBICIN-P3-STS-01, EORTC 1202, REGOBONE, HGUS EORTC-62113-55115-STBSG-GCG, CYCLIGIST, EORTC 62005, EORTC 62011, EORTC 62991-22998, EORTC 62022, RAPIRI, BERNIE BO20924, TED12318, CSTI571X2103, NBTXR3, CSTI571X2101-BKM120, NP28021, PeComa, DOVIGIST, AB07001, VE-BASKET, AB11002, E7389-G000-309 ESAI, AB04030, Y-Image, PALETTE VEG110727 62072, VEG105430 GW786034, PO4720, E7389-E044-207 / EORTC 62052, A6181112, A6181004, A6181047, SUCCEED AP 23573-07-32, H3E-EW-S115, CAMN 107 A2103, CAMN 107 A2201, CAMN 107 G2301, CAMN 107 DDE06, CSTI571 JDE74, AMG162 20042006, EPIGIST, EFC 10145, SARC 011 N021157, ET-C-002-07, SABINE, AMG 655 20060324, ET-B-028-06, ET743-OVC-1001, CP13-0707, NP22890, OP690, PICASSO IPM 3001, BAY 73-4506/14874, IPI-926-04, NO21280, NGR-hTNF NGR 016, ET-B008-98 ET743, CSTI571 0203 EORTC 62001-16003 , CRAD001C 2206 , ET743-STS-201 , AB04016, ET743-SAR-1001 , 62043 EORTC, MORAb-004, TH-CR-406 / SARC 021, BP27772, A6181196, BRF 117019 , A4021020, ATRIGE, ZALYPSIS PM104-B-003-10, NBTXR3 301, LDE225, GENSARC, PVNS, VERSATIS faisabilité, NFITOR, NUTLIN 3 - MDM-2 - RO5503781, LEE011 phase I/II liposarcome, LEE011 phase I tumeurs solides, TSAR, CHDM201X2103C, Euro Ewing 2012, PEMBROSARC, SBRT Pédiatrie, ICGC LEIOMYOSARCOMES GSF, BP29428, MARGIC : Evaluation médico-économique, CCGM097X2101, GENMODIF, EQUIMETH2, HEPATOFLUO, MOST (My Own Specific Therapy), SHIVA - Phase II Preuve de concept, MOZOBIL15609 , SALTO-BIO , SALTO-2, SALTO, PACIFIK- GP28153, ABI-007-PST-001 - pédiatrie, KF5503-66, PROSPECTYON, AMG 232, rEECur EORTC 1403: sarcome d'Ewing, GC-BIO-IPC 2013-010, PERMED01-IPC 2014-003, ALTITUDES-1508 , RADIOSARP, PROPAN01, MorphinOgel, GEIS-32 , BLU-285-1101, EZH-202 , PLX108-10, OTMRG, GO28399, ALT GIST, MEME, CRYODESMO, MAPPYACTS, MO29518 BASKET, TRASTS, ET16-047 GIGIST-LB, I5B-MC-JGDJ : ANNOUNCE Ph III, I5B-MC-JGDM , MOTION - méta osseuses - Cryoablation, FIVE PRIME FPA008-002, AcSé-eSMART-CSET, LMS-04, HOPE 207, COMBINAIR3, IMODI, STARTRK-2 (RXDX-101-02), STOP MUCITES , MetZolimOS, ISI-JX, CLDK378A2407 ASCEND10, THEODORA, CABOGIST EORTC 1317 , RNASARC, CRAD001X2109, AVARTHEC, REVENRI, DCC-2618-03-001 INVICTUS, AcSé pembrolizumab, ANITA EORTC1506 , 20140114 DENO, XGEVA AMGEN 20150360, MICCHADO, TAPPAS 105SAR301 TRACON , PROFILER 02, EORTC-1506-STBSG-ANITA, KCP-330-020 SEAL :Selinexor vs Placebo liposarcome, TRAMUNE : ph IB_trabectidine Durvalumab , IsèreADOM, PHRC ETOILE, Sarcome 13 / OS2016, I6F-MC-JJCD, ALCINA, CA209-848, BLU-285-1303 VOYAGER, EORTC 1447-STBSG, EZH-501, NEOSARCOMICS, METRO PD1, RT-Immune, REGOMUNE, ARO-012 CRENOGIST, ETIOSARC, 1443.0001 : phI_BI765063 , DCC-2618-03-002 INTRIGUE, EREMISS: Ph II_regorafenif en maintenance_sarcome, 2102-ONC-102: Ph Ib/II_FT-2102t , COTESARC ML41313, BFR ESS 01: sarcome stromal de l'endomètre, REGISTRI, cirsarc, CONGRATS, E7389-G000-213, 1200.120 : afatinib, PAIRS AJA, CHANCE, ONCOVID-19: SRAS-COV2 , MULTISARC C16-40, REGOSTAT, MEDIPA, SPECTA EORTC 1553, MEGAMOST, 42756493CAN2002 RAGNAR, ONCOVID-21, ADP-0044-002 SPEARHEAD 1, PROTONBIOMARKS: biomarqueurs_ péd et adultes, PASCA: PArcours de Santé au cours du CAncer, LENVAGIST: ph II_lenvatinib + MSS vs MSS_GIST, RAR-IMMUNE, KETACANCER , 208467 IGNYTE ESO, CHIC STS 01, Ce NGEPS-GMFMel ("RIC MEL") , ANRS0001S CoV-POPART , RTSG 2016 UMBRELLA , SUDOPED, PRESOV, REGOMAIN, EORTC 1809STRASS 2, PLANET, AMPHISARC: Ph I/II, OP2C - Observatoire, SACHA: Etude prospective obs_péd, MIRAS, EORTC QLG: sarcome _ QDV, GERICO 14 , ATEZOGIST, GSK 213406, DUNE, AVIATOR2020, FHD-609-C-001, ZN-c3-003, RADIOSARC: MR004 RT _sarcome tissus mous , INBRX109: ph II_ INBRX-109 chondrosarcome, BI 1403-0008, OSII-TTP, MK7902-013, THERAC, PTC596-ONC-008, FaR-RMS, TARSARC : Ph II_ sarcome tissus mous ATR, STEREOSARC, FORTEe : Fort contre le cancer, RAIN-3201 MANTRA, TPN-RAD, IMPRESARC, OSE-279 - C101, ADCT-601-102, TRacKING, PICCandGLUE, GO42286, PH-L19TNFDOX2-03/16 FIBROSARC, TORNADO, NB003-01, BEVANEC, PM1183-C-010-22, DEBOUT-HOSPIT, PH-L19TNFSARC-03/18 FLASH: sarcome tissus mous, IDRX-42-001, PROPHYLOXITIN, SarQuantIRM, CGT9486-21-301(PEAK), AcSé – Vemurafenib , PEMBROCABOSARC, HYPOSARC, PM1183-C-010-22 SALUDO, REGO INTER EWING-1, MAPPYACTS 2, DCC-2618-03-003 (INSIGHT), LPSM, COHEC: PhIII_RIPH2, INBRX-109 EWING , OnKOT&T 2.0, Pelvtilt-RT, Sleep-4-all-2.0, DS2243-054 , CANUT Junior, L-UteCIN , ePPS-2202, HOPAYA, CRYODESMO-2, IMC-P115C-1005, OMX-0407-101: PhIb_ OMX-0407 , CHONQUER, PREDOSTAR: Ph II_Dostarlimab, QF-EXPERT: RIPH3, GIST-Ten , ADCE-D01-001 Adcendo , LIGHT-CTC, TANGENT SNX-301-020, StrateGIST 3, AFTERGYN, EZHiSWITCH CSET 2024, StrateGIST 3 IDRX-42-301, ESPACE, PREDCAP

Clinical trial other
Type : Free value	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description :

Centre of treatment
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description : Établissement dans lequel le patient est inclus dans l'essai clinique
Possible values : CC Bordeaux CLCC/CHU, CC Lyon CLCC/CHU, CC IGR, CE Angers CLCC/CHU, CE Besançon CLCC/CHU, CE Caen CLCC/CHU, CE Clermond-Ferrand CLCC/CHU, CE Dijon CLCC/CHU, CE La Réunion, CE Lille CLCC/CHU, CE Limoges CHU, CE Marseille CHU Timone, CE Marseille CLCC, CE Montpellier CLCC/CHU, CE Nancy CLCC/CHU, CE Nantes CLCC, CE Nantes CHU, CE Nice CLCC/CHU, CE Paris Pitié Salpétrière, CE Paris Tenon , CE Paris Cochin, CE Paris Curie , CE Paris Saint Louis, CE Reims CLCC/CHU, CE Rennes/Brest CLCC/CHU, CE Rouen CLCC/CHU, CE Strasbourg CLCC/CHU, CE Toulouse CLCC/CHU, CE Tours CHU, Autre